T11	Chemical 267 270	His
T12	Chemical 313 316	His
T13	Disease 512 515	AMD
T15	Biomarker 517 652	age-related changes in glycosaminoglycan structures such as a decrease in the sulfation of HS, together with the presence of FH His-402
T16	Chemical 731 734	His
T17	Chemical 979 998	sucrose octasulfate
T18	Chemical 1075 1078	Tyr
T19	Variant 1140 1145	Y402H
T2	Disease 92 95	AMD
#10	AnnotatorNotes T2	DOID:10871
T20	Disease 1151 1154	AMD
T22	Biomarker 1191 1244	complement variants in CFH and other complement genes
T23	Disease 1265 1268	AMD
T25	Disease 1286 1289	AMD
T27	Disease 1416 1419	AMD
T29	Variant 1438 1444	R1210C
T30	Disease 1453 1456	AMD
T32	Disease 1584 1587	AMD
T34	Variant 1640 1644	V62I
T4	Disease 118 121	AMD
T6	Variant 140 145	Y402H
T7	Biomarker 158 192	Individuals homozygous for His-402
T8	Chemical 185 188	His
T9	Disease 236 239	AMD
T3	Gene-Protein 97 99	FH
R1	Variant-Of Arg1:T3 Arg2:T6	
R2	Risk-Factor Arg1:T6 Arg2:T4	
#2	AnnotatorNotes T6	p.Tyr402His
R3	Risk-Factor Arg1:T7 Arg2:T9	
T5	Biomarker 254 288	2.5-fold for His-402 heterozygotes
R4	Association Arg1:T5 Arg2:T9	
T10	Gene-Protein 354 356	FH
T35	Gene-Protein 381 383	FH
T36	Gene-Protein 397 399	FH
T37	Gene-Protein 411 414	CRP
#3	AnnotatorNotes T37	HGNC:2367
T38	Gene-Protein 444 446	FH
T39	Chemical 458 460	HS
T14	Gene-Protein 642 644	FH
R5	Association Arg1:T15 Arg2:T13	
T40	Gene-Protein 683 685	FH
T41	Gene-Protein 728 730	FH
T42	Chemical 790 792	HS
T43	Chemical 608 610	HS
T44	Chemical 852 854	HS
T45	Chemical 871 874	His
T46	Chemical 889 892	His
R6	Association Arg1:T19 Arg2:T20	
T21	Gene-Protein 1214 1217	CFH
#4	AnnotatorNotes T21	HGNC:4883
R7	Variant-Of Arg1:T21 Arg2:T19	
R8	Association Arg1:T22 Arg2:T23	
T24	Gene-Protein 1393 1395	FH
R9	Variant-Of Arg1:T24 Arg2:T29	
R10	Risk-Factor Arg1:T29 Arg2:T27	
#5	AnnotatorNotes T29	p.Arg1210Cys
T26	Biomarker 1487 1528	rare variants in FH in its signal peptide
T28	Gene-Protein 1504 1506	FH
R11	Association Arg1:T26 Arg2:T30	
#6	AnnotatorNotes T34	p.Val62Ile
T31	Biomarker 1689 1744	noncoding variants in a region overlapping the CFH gene
T33	Gene-Protein 1736 1739	CFH
R12	Variant-Of Arg1:T33 Arg2:T34	
T47	Biomarker 1767 1818	genetic variants in complement C3, CFI, CFB, and C9
T48	Gene-Protein 1798 1800	C3
#7	AnnotatorNotes T48	HGNC:1318
T49	Gene-Protein 1802 1805	CFI
#8	AnnotatorNotes T49	HGNC:5394
T50	Gene-Protein 1807 1810	CFB
#9	AnnotatorNotes T50	HGNC:1037
T51	Gene-Protein 1816 1818	C9
#11	AnnotatorNotes T51	HGNC:1358
T52	Collection 1689 1818	noncoding variants in a region overlapping the CFH gene ( 36 , 46 , 47 ), and genetic variants in complement C3, CFI, CFB, and C9
R13	Risk-Reduce Arg1:T34 Arg2:T32	
R14	Association Arg1:T52 Arg2:T32	
T1	Chemical 952 969	glycosaminoglycan
T53	Gene-Protein 50 52	FH
#1	AnnotatorNotes T53	HGNC:4883
T54	ProteinDomain 100 105	SCR-7
T55	ProteinDomain 357 364	SCR-6/8
T56	ProteinDomain 753 758	SCR-7
T57	ProteinDomain 900 907	SCR-6/8
T58	ProteinDomain 1397 1403	SCR-20
T59	ProteinDomain 1535 1540	SCR-1
T60	ProteinDomain 1542 1549	SCR-3/5
T61	ProteinDomain 1551 1556	SCR-8
T62	ProteinDomain 1558 1564	SCR-16
T63	ProteinDomain 1569 1575	SCR-18
T64	ProteinDomain 1648 1653	SCR-1
T65	Chemical 330 337	heparin
T66	Chemical 1369 1376	heparin
T67	Biomarker 30 52	Genetic variants in FH
R15	Association Arg1:T67 Arg2:T2	
T68	Chemical 540 557	glycosaminoglycan
